英夫利西单抗-话题@MedSci

#英夫利西单抗#

16篇内容 | 1077人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2197747, encodeId=4113219e747d0, content=<a href='/topic/show?id=fde528896bd' target=_blank style='color:#2F92EE;'>#克罗恩病#</a> <a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=IBD：皮下注射与静脉注射英夫利昔单抗维持治疗炎症性肠病患者的1年临床结果比较, objectType=article, longId=820907, objectId=580282090ec7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/abdominal-pain-s2a-photo-of-pain-area-and-internal-abdominal-organs.jpg, objectUrl=/article/show_article.do?id=580282090ec7, replyNumber=0, likeNumber=14, createdTime=2024-04-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=580282090ec7, moduleTitle=IBD：皮下注射与静脉注射英夫利昔单抗维持治疗炎症性肠病患者的1年临床结果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=580282090ec7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2154567, encodeId=718a215456e43, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a> 肛周克罗恩病（pCD）是克罗恩病（CD）的一种使人衰弱且具有侵袭性的表型，影响多达三分之一的克罗恩病患者。pCD的致残症状和并发症深刻影响患者的生活质量。pCD患者有多种肛周表现，包括瘘管、脓肿、肛裂、皮赘和肛门狭窄。约26%的克罗恩病患者在诊断后的最初20年内发生肛周瘘管（CD-PAF）。在用于CD-PAF的各种全身性医学治疗、手术技术和局部治疗中，抗肿瘤坏死因子（TNF）药物自二十多年前被证实有效以来一直是治疗的基石。, objectTitle=英夫利西单抗, objectType=topic, longId=87123, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=21, createdTime=2023-08-25, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=浙江省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1323158, encodeId=05d81323158c1, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=FDA咨询委员会反对批准罗沙司他上市国产英夫利西单抗获批, objectType=article, longId=214474, objectId=d00b2144e456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d00b2144e456, replyNumber=0, likeNumber=40, createdTime=2021-07-21, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d00b2144e456, moduleTitle=FDA咨询委员会反对批准罗沙司他上市国产英夫利西单抗获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d00b2144e456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323157, encodeId=41a3132315eba, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=AP&T：英夫利西单抗诱导方案在治疗激素难治性急性重症结肠炎中的疗效分析, objectType=article, longId=179081, objectId=a4dd1e90814e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4dd1e90814e, replyNumber=0, likeNumber=41, createdTime=2019-09-09, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4dd1e90814e, moduleTitle=AP&T：英夫利西单抗诱导方案在治疗激素难治性急性重症结肠炎中的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4dd1e90814e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323156, encodeId=ab7c1323156be, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=Arthritis Res Ther：英夫利西单抗治疗白塞病难治性葡萄膜视网膜炎怎么样？, objectType=article, longId=160809, objectId=130116080969, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=130116080969, replyNumber=0, likeNumber=32, createdTime=2019-02-24, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=130116080969, moduleTitle=Arthritis Res Ther：英夫利西单抗治疗白塞病难治性葡萄膜视网膜炎怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=130116080969)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323155, encodeId=08e7132315590, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=Inflamm Bowel Dis：英夫利西单抗治疗克罗恩病，不同治疗目标，不同血药浓度, objectType=article, longId=151102, objectId=435c1511029d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=435c1511029d, replyNumber=0, likeNumber=46, createdTime=2018-10-17, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=435c1511029d, moduleTitle=Inflamm Bowel Dis：英夫利西单抗治疗克罗恩病，不同治疗目标，不同血药浓度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=435c1511029d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323154, encodeId=2dfa132315407, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=IBD：治疗期间英夫利西单抗浓度与IBD患者的疾病缓解存在相关关系, objectType=article, longId=150359, objectId=aeab1503593b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aeab1503593b, replyNumber=0, likeNumber=67, createdTime=2018-10-06, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aeab1503593b, moduleTitle=IBD：治疗期间英夫利西单抗浓度与IBD患者的疾病缓解存在相关关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aeab1503593b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323153, encodeId=cb7113231539f, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=JCC：反应性试验后主动监测英夫利西单抗浓度可以获得更好的临床结局, objectType=article, longId=142468, objectId=7a0f1424689f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a0f1424689f, replyNumber=0, likeNumber=40, createdTime=2018-07-06, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a0f1424689f, moduleTitle=JCC：反应性试验后主动监测英夫利西单抗浓度可以获得更好的临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a0f1424689f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323152, encodeId=8781132315286, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=DCR：内脏脂肪面积与英夫利西单抗治疗克罗恩病粘膜愈合有关, objectType=article, longId=139322, objectId=168b1393229c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=168b1393229c, replyNumber=0, likeNumber=0, createdTime=2018-05-30, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=168b1393229c, moduleTitle=DCR：内脏脂肪面积与英夫利西单抗治疗克罗恩病粘膜愈合有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=168b1393229c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323151, encodeId=87201323151bd, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=Clin Gastroenterol H：持续缓解的克罗恩氏病患者：英夫利西单抗停药7年后的结局, objectType=article, longId=133806, objectId=f3f31338067c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3f31338067c, replyNumber=0, likeNumber=31, createdTime=2018-03-31, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3f31338067c, moduleTitle=Clin Gastroenterol H：持续缓解的克罗恩氏病患者：英夫利西单抗停药7年后的结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3f31338067c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323150, encodeId=11261323150b1, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=JCC：急性重症结肠炎早期使用英夫利西单抗应答预测生物标志物的探索：一项前瞻性研究, objectType=article, longId=133253, objectId=5fca13325356, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fca13325356, replyNumber=0, likeNumber=36, createdTime=2018-03-25, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fca13325356, moduleTitle=JCC：急性重症结肠炎早期使用英夫利西单抗应答预测生物标志物的探索：一项前瞻性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fca13325356)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323149, encodeId=b7d313231493e, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=JCC：英夫利西单抗治疗小儿克罗恩病粪便微生物特征及变化, objectType=article, longId=123046, objectId=3bba123046df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bba123046df, replyNumber=0, likeNumber=30, createdTime=2017-12-13, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bba123046df, moduleTitle=JCC：英夫利西单抗治疗小儿克罗恩病粪便微生物特征及变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bba123046df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323148, encodeId=b56b13231484c, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=杨森修订类克®（英夫利西单抗）说明书, objectType=article, longId=121293, objectId=3270121293e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3270121293e4, replyNumber=0, likeNumber=35, createdTime=2017-11-26, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3270121293e4, moduleTitle=杨森修订类克®（英夫利西单抗）说明书, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3270121293e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323147, encodeId=d903132314e1d, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=Clin Gastroenterol Hepatol：监测IBD患者英夫利西单抗血药浓度：主动vs被动, objectType=article, longId=118585, objectId=cb5e11858529, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb5e11858529, replyNumber=0, likeNumber=28, createdTime=2017-11-04, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb5e11858529, moduleTitle=Clin Gastroenterol Hepatol：监测IBD患者英夫利西单抗血药浓度：主动vs被动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb5e11858529)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323146, encodeId=f590132314660, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=IBD：IL-9可以预测克罗恩病疾病活动度并且判断英夫利西单抗的疗效, objectType=article, longId=117944, objectId=49c311e944f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49c311e944f4, replyNumber=0, likeNumber=31, createdTime=2017-10-29, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49c311e944f4, moduleTitle=IBD：IL-9可以预测克罗恩病疾病活动度并且判断英夫利西单抗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49c311e944f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323145, encodeId=065113231450a, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=Aliment Pharmacol Ther：较高的英夫利西单抗谷水平与克罗恩氏病患者肛周瘘愈合相关, objectType=article, longId=95515, objectId=3ac0955155e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ac0955155e, replyNumber=0, likeNumber=31, createdTime=2017-04-13, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ac0955155e, moduleTitle=Aliment Pharmacol Ther：较高的英夫利西单抗谷水平与克罗恩氏病患者肛周瘘愈合相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ac0955155e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1323144, encodeId=dbf61323144ff, content=<a href='/topic/show?id=b31c8e12398' target=_blank style='color:#2F92EE;'>#英夫利西单抗#</a>, objectTitle=Nat Med：上海免疫所研究者发现英夫利西单抗通过FOXP3磷酸化修复RA患者受损的Treg细胞功能, objectType=article, longId=18716, objectId=967118e1644, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=967118e1644, replyNumber=0, likeNumber=47, createdTime=2013-05-16, rootId=0, userName=ms9651749636653578, userId=47102500004, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=967118e1644, moduleTitle=Nat Med：上海免疫所研究者发现英夫利西单抗通过FOXP3磷酸化修复RA患者受损的Treg细胞功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=967118e1644)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

英夫利西单抗

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#克罗恩病# #英夫利西单抗#

IBD：皮下注射与静脉注射英夫利昔单抗维持治疗炎症性肠病患者的1年临床结果比较

2024-04-10发表于上海

yangchou (审核中...)

前往app查看评论内容

全文收起 #英夫利西单抗# 肛周克罗恩病（pCD）是克罗恩病（CD）的一种使人衰弱且具有侵袭性的表型，影响多达三分之一的克罗恩病患者。pCD的致残症状和并发症深刻影响患者的生活质量。pCD患者有多种肛周表现，包括瘘管、脓肿、肛裂、皮赘和肛门狭窄。约26%的克罗恩病患者在诊断后的最初20年内发生肛周瘘管（CD-PAF）。在用于CD-PAF的各种全身性医学治疗、手术技术和局部治疗中，抗肿瘤坏死因子（TNF）药物自二十多年前被证实有效以来一直是治疗的基石。

2023-08-25发表于浙江省

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

FDA咨询委员会反对批准罗沙司他上市国产英夫利西单抗获批

2021-07-21

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

AP&T：英夫利西单抗诱导方案在治疗激素难治性急性重症结肠炎中的疗效分析

2019-09-09

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

Arthritis Res Ther：英夫利西单抗治疗白塞病难治性葡萄膜视网膜炎怎么样？

2019-02-24

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

Inflamm Bowel Dis：英夫利西单抗治疗克罗恩病，不同治疗目标，不同血药浓度

2018-10-17

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

IBD：治疗期间英夫利西单抗浓度与IBD患者的疾病缓解存在相关关系

2018-10-06

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

JCC：反应性试验后主动监测英夫利西单抗浓度可以获得更好的临床结局

2018-07-06

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

DCR：内脏脂肪面积与英夫利西单抗治疗克罗恩病粘膜愈合有关

2018-05-30

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

Clin Gastroenterol H：持续缓解的克罗恩氏病患者：英夫利西单抗停药7年后的结局

2018-03-31

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

JCC：急性重症结肠炎早期使用英夫利西单抗应答预测生物标志物的探索：一项前瞻性研究

2018-03-25

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

JCC：英夫利西单抗治疗小儿克罗恩病粪便微生物特征及变化

2017-12-13

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

杨森修订类克®（英夫利西单抗）说明书

2017-11-26

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

Clin Gastroenterol Hepatol：监测IBD患者英夫利西单抗血药浓度：主动vs被动

2017-11-04

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

IBD：IL-9可以预测克罗恩病疾病活动度并且判断英夫利西单抗的疗效

2017-10-29

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

Aliment Pharmacol Ther：较高的英夫利西单抗谷水平与克罗恩氏病患者肛周瘘愈合相关

2017-04-13

ms9651749636653578 (审核中...)

前往app查看评论内容

#英夫利西单抗#

Nat Med：上海免疫所研究者发现英夫利西单抗通过FOXP3磷酸化修复RA患者受损的Treg细胞功能

2013-05-16

科室
- - 订阅+
  - 更多科室
工具
服务